Global Radiopharmaceuticals Market Size, Trends, and Growth Opportunity, By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), By Application (Diagnostic Applications, Therapeutic Applications), By Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others), By Region and Forecast to 2030.
Global Radiopharmaceuticals Market 
The Global Radiopharmaceuticals Market was valued at USD 5.15 billion in 2022 and is expected to expand to USD 12.17 billion by 2030, at a CAGR of 8.46% during the forecast period 2023- 2030.
Radiopharmaceuticals or medicinal radio compounds are a group of pharmaceutical drugs that contains radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents to produce images of organs & tissues of interest, a process that is called scintigraphy.
Radiopharmaceuticals also called a radioactive drug, is a type of drug that contains a radioactive substance and is used to diagnose & treat disease, which includes cancer.
Market Drivers
The increase in the number of cases of cancer and heart disease is one of the major factors boosting the market growth. In 2020, WHO stated that cancer would be responsible for approx. 10 million deaths globally. Furthermore, in 2020, the American Cancer Society stated that approx. 1,806,590 new cancer cases can be diagnosed.
Also, growing R&D activities associated with radiopharmaceuticals and rising demand for nuclear imaging technologies is boosting the global radiopharmaceuticals market growth during the forecast period 2030.
Market Restraints
Many side-effects of radiopharmaceuticals restrain the market growth. Side effects such as chills, drowsiness, difficulty breathing, redness of the skin, vomiting, nausea, skin rash, itching, headache, and stomach pain. Therefore, these factors hinder market growth.
Market Segmentation
The global radiopharmaceuticals market is segmented into type, application, procedural volume assessment, end user, and region.
Based on type, the global radiopharmaceuticals market is segmented into diagnostic nuclear medicine and therapeutic nuclear medicine.
Regional Analysis
The global radiopharmaceuticals market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the radiopharmaceuticals market due to the huge base of healthcare facilities and rising overweight population base. Also, the huge presence of the patient population suffering from chronic diseases and the increasing number of research activities in this region are boosting the market growth.

Key Players
Various key players are discussed in the global radiopharmaceuticals market report including; Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer AG, Bracco Imaging, Nordion, Braun Melsungen AG, NTP Radioisotopes, NorthStar Medical Radioisotopes, Eckert & Ziegler, and Others.
For Instance, in 2021, NorthStar Medical Radioisotopes, LLC, a global radiopharmaceutical developer, and GE Healthcare entered a partnership agreement to manufacture and distribute iodine-123 (I-123) capsules in the U.S.A The product shall assist GE Healthcare in enhancing its product portfolio and boosting its market position.
Market Taxonomy
By Type
•        Diagnostic Nuclear Medicine
•        SPECT Radiopharmaceuticals
•        Technetium-99m
•        Thallium-201
•        Gallium-67
•        Iodine-123
•        Therapeutic Nuclear Medicine
•        Alpha Emitters
•        Ra-223
•        Brachytherapy Isotopes
•        Intoiodine-125
•        Palladium-103
•        Cesium-131
•        Iridium-192
By Application
•        Diagnostic Applications
•        SPECT Applications
•        Cardiology
•        Bone Scans
•        Thyroid Applications
•        Pulmonary Scans
•        Therapeutic Applications
•        Thyroid Indications
•        Bone Metastasis
•        Lymphoma
•        Endocrine Tumors
By Procedural Volume Assessment
•        Diagnostic Procedures
•        Therapeutic Procedures
By End User
•        Hospitals
•        Ambulatory Surgical Centers
•        Diagnostic Centers
•        Cancer Research Institutes
•        Others
By Region
•        North America
•        Latin America
•        Europe
•        Asia Pacific
•        Middle East & Africa

Global Radiopharmaceuticals Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Radiopharmaceuticals Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact Due To Recent Energy Crisis
4.2.5 Cumulative Impact Due Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact Of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Radiopharmaceuticals Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Radiopharmaceuticals Market Share Analysis, By Type
5.3 Global Radiopharmaceuticals Market Size and Forecast, By Type
5.3.1 Diagnostic Nuclear Medicine
5.3.1 SPECT Radiopharmaceuticals
5.3.2 Technetium-99m
5.3.3 Thallium-201
5.3.4 Gallium-67
5.3.5 Iodine-123
5.3.6 Therapeutic Nuclear Medicine
5.3.7 Alpha Emitters
5.3.8 Ra-223
5.3.9 Brachytherapy Isotopes
5.3.10 Intoiodine-125
5.3.11 Palladium-103
5.3.12 Cesium-131
5.3.13 Iridium-192
6 Global Radiopharmaceuticals Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Radiopharmaceuticals Market Share Analysis, By Application
6.3 Global Radiopharmaceuticals Market Size and Forecast, By Application
6.3.1 Diagnostic Applications
6.3.2 SPECT Applications
6.3.3 Cardiology
6.3.4 Bone Scans
6.3.5 Thyroid Applications
6.3.6 Pulmonary Scans
6.3.7 Therapeutic Applications
6.3.8 Thyroid Indications
6.3.9 Bone Metastasis
6.3.10 Lymphoma
6.3.11 Endocrine Tumors
7 Global Radiopharmaceuticals Market, By Procedural Volume Assessment
7.1 Y-o-Y Growth Comparison, By Procedural Volume Assessment
7.2 Global Radiopharmaceuticals Market Share Analysis, By Procedural Volume Assessment
7.3 Global Radiopharmaceuticals Market Size and Forecast, By Procedural Volume Assessment
7.3.1 Diagnostic Procedures
7.3.2 Therapeutic Procedures
8 Global Radiopharmaceuticals Market, By End-use
8.1 Y-o-Y Growth Comparison, By End-use
8.2 Global Radiopharmaceuticals Market Share Analysis, By End-use
8.3 Global Radiopharmaceuticals Market Size and Forecast, By End-use
8.3.1 Hospitals
8.3.2 Ambulatory Surgical Centers
8.3.3 Diagnostic Centers
8.3.4 Cancer Research Institutes
8.3.5 Others
9 Global Radiopharmaceuticals Market, By Region
9.1 Global Radiopharmaceuticals Market Share Analysis, By Region
9.2 Global Radiopharmaceuticals Market Share Analysis, By Region
9.3 Global Radiopharmaceuticals Market Size and Forecast, By Region
10 North America Radiopharmaceuticals Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 North America Radiopharmaceuticals Market Share Analysis, By Type
10.3 North America Radiopharmaceuticals Market Size and Forecast, By Application
10.4 North America Radiopharmaceuticals Market Size and Forecast, By Procedural Volume Assessment
10.5 North America Radiopharmaceuticals Market Size and Forecast, By End-use
10.6 North America Radiopharmaceuticals Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11 Europe Radiopharmaceuticals Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Europe Radiopharmaceuticals Market Share Analysis, By Type
11.3 Europe Radiopharmaceuticals Market Size and Forecast, By Application
11.4 Europe Radiopharmaceuticals Market Size and Forecast, By Procedural Volume Assessment
11.5 Europe Radiopharmaceuticals Market Size and Forecast, By End-use
11.5 Europe Radiopharmaceuticals Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4 Rest of Europe
12 Asia Pacific Radiopharmaceuticals Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Asia Pacific Radiopharmaceuticals Market Share Analysis, By Type
12.3 Asia Pacific Radiopharmaceuticals Market Size and Forecast, By Application
12.4 Asia Pacific Radiopharmaceuticals Market Size and Forecast, By Procedural Volume Assessment
12.5 Asia Pacific Radiopharmaceuticals Market Size and Forecast, By End-use
12.6 Asia Pacific Radiopharmaceuticals Market Size and Forecast, By Country
12.6.1 China        
12.6.2 Japan
12.6.3 India
12.6.4 Rest of Asia Pacific
13 Latin America Radiopharmaceuticals Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Latin America Radiopharmaceuticals Market Share Analysis, By Type
13.3 Latin America Radiopharmaceuticals Market Size and Forecast, By Application
13.4 Latin America Radiopharmaceuticals Market Size and Forecast, By Procedural Volume Assessment
13.5 Latin America Radiopharmaceuticals Market Size and Forecast, By End-use
13.6 Latin America Radiopharmaceuticals Market Size and Forecast, Country
13.6.1 Brazil
13.6.2 Rest of Latin America
14 Middle East Radiopharmaceuticals Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Middle East Radiopharmaceuticals Market Share Analysis, By Type
14.3 Middle East Radiopharmaceuticals Market Size and Forecast, By Application
14.4 Middle East Radiopharmaceuticals Market Size and Forecast, By Procedural Volume Assessment
14.5 Middle East Radiopharmaceuticals Market Size and Forecast, By End-use
14.6 Middle East Radiopharmaceuticals Market Size and Forecast, By Country
14.6.1 Saudi Arabia
14.6.2 UAE
14.6.3 Egypt
14.6.4 Kuwait
14.6.5 South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market Share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Cardinal Health
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 GE Healthcare
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Lantheus Medical Imaging
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Bayer AG
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Bracco Imaging
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Nordion
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Braun Melsungen AG
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies        
16.8 NTP Radioisotopes
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 NorthStar Medical Radioisotopes
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Eckert & Ziegler
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies